Draft:Gobardhan Das (director)
| Submission declined on 23 July 2024 by SafariScribe (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Prof. Gobardhan Das | |
|---|---|
| Born | Dec 10, 1966 Burdwan, West Bengal |
| Nationality | Indian |
| Alma mater | Institute of Microbial Technology, Chandigarh |
| Scientific career | |
| Fields | Immunology - Host Pathogen Relationship |
 |
 | It has been suggested that this page be merged into Draft:Gobardhan Das. (Discuss) Proposed since July 2024. |
Gobardhan Das is the Director.[1] of the Indian Institute of Science Education and Research Bhopal (IISER Bhopal). Prior to assuming this position, Das was a Professor and Chair of the Special Centre for Molecular Medicine at Jawaharlal Nehru University, New Delhi. Prof. Das inspirational leadership has the potential to create a ripple effect of positive change in the institute. By fostering a culture of innovation, collaboration, personal growth, and adaptability, the institute can experience significant growth and development under his guidance.
Education
[edit]Prof. Das completed his doctorate (Ph.D.) in Immunology - Host pathogen relationship, from the Institute of Microbial Technology, Chandigarh in 1997. He is associated with professional organizations such as Molecular Immunology Forum, and Guha Research Council. Das also holds editorial positions as associate editor in various journals.
Profession
[edit]Prof. Das also holds honorary positions as Adjunct Professor, Houston Methodist Research Institute, Houston, USA, and Adjunct Professor, Shoochow University, Suzhou, China. Precisely, he served as visiting Professor in many renowned Universities amongst the worlds. He visited USA, Canada, Australia, Japan, China, Finland, Greece, England with various task.
He has been awarded with various awards and honors, few notable are: Fellow "TATA Innovation fellowship", 2023; Fellow of “Indian Academy of Sciences”, Bangalore (FASC) 2018; Fellow of “The National Academy of Sciences”, Allahabad (FNASc) 2011; Fellow of “West Bengal Academy of Sciences and Technology”, 2014; Fellow of “[https://www.indiaalliance.org/ Welcome Trust-DBT Senior Fellowship]”, 2009; Fellow of “Ramalingaswami Fellowship”, 2008; Fellow of “National Research Foundation” Govt. of South Africa, 2013.
Das served in many important decision-making committees. He has served in various task forces in DBT, DST and ICMR.
Awards and Honours
[edit]Fellow "TATA Innovation fellowship" 2023.
Fellow of “Indian Academy of Sciences”, Bangalore (FASC) 2018.
Fellow of “The National Academy of Sciences”, Allahabad (FNASc) 2011.
Fellow of “West Bengal Academy of Sciences and Technology”, 2014.
Fellow of “Welcome Trust-DBT Senior Fellowship”, 2009.
Fellow of “Ramalingaswami Fellowship”, 2008.
Fellow of “National Research Foundation” Govt. of South Africa, 2013.
BD-Bioscience-TCS award, 2011.
Sanofi-Aventis achievement spot award 2006.
Outstanding faculty service award 2005, UMDNJ, New Jersey.
Post-doctoral fellowship, Howard Hughes Medical Institute, 1998.
Senior Research Fellowship, Council for Scientific and Industrial Research, 1995.
Junior Research Fellowship, Council for Scientific and Industrial research,
1992.Department of Biotechnology fellowship for M.Sc (Biotech), J.N.U., 1989.
Publications
[edit]8. Dhiraj Kumar Singh, Sultan Tousif, Ashima Bhaskar, Annu Devi, Kriti Negi, Barnani Moitra, Anand Ranganathan, Ved Prakash Dwivedi, Gobardhan Das. (2021). Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis. PLoS Pathog 17(8): e1009805. https://doi.org/10.1371/journal.ppat.1009805.[2]
7. Dhiraj Kumar Singh, Sultan Tousif, Ved Prakash Dwivedi, Samreen Fatima, Anand Ranganathan, Gobardhan Das (2021). Luteolin enhances antibiotic treatment of tuberculosis by promoting central memory T cell responses. PlosPathogens: 17:e1009805.[3]
6. Shaheer Ahmad, Debapriya Bhattacharya, Neeta Gupta, Varsha Rawat, Sultan Tousif, Luc Van Kaer, Gobardhan Das. (2021). Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells PLoS Pathog 16(5): e1008356. https://doi.org/10.1371/journal.ppat.1008356[4].
5. Dhiraj Kumar Singh, Sultan Tousif, Ved Prakash Dwivedi, Anand Ranganathan, Gobardhan Das. (2020). Luteolin-mediated Kv1.3 K+ Channel inhibition augments BCG vaccine efficacy by promoting central memory T cell responses. PlosPathogens. 16:e1008887[5].
4. Samit Chatterjee, Ved Prakash Dwivedi, Yogesh Singh, Imran Siddiqui, Pawan Sharma, Luc Van Kaer, and Gobardhan Das (2011). Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent manner. PLoSPathog 7: e1002378[6]. (** Appeared in National and international News)
3. Shilpa Raghuvanshi, Sarman Singh, Luc Van Kaer, and Gobardhan Das. (2010). Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc. Natl. Acad. Sci. 107: 21653-21658[7]. (** Appeared in National and News: covered in 90 countries in various languages)
2. Jyoti Das, Luc Van Kaer, Alfred M Bothwell, Yufang Shi, and Gobardhan Das. (2009). Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med; 206:2407-16[8]. (** Editor’s Choice)
1. Jyoti Das, Paul Eynott, Ray Jupp, Luc Van Kaer, Alfred M Bothwell, Yufang Shi, and Gobardhan Das. (2006) NKT cells and CD8+ T-cells are dispensable in a CD4+ T- cell dependent model of allergic airways inflammation. Nat. Med. 12: 1345-1346[9]
References
[edit]- ^ "Institute | Directorate". www.iiserb.ac.in. Retrieved 2024-07-23.
- ^ Singh, Dhiraj Kumar; Tousif, Sultan; Bhaskar, Ashima; Devi, Annu; Negi, Kriti; Moitra, Barnani; Ranganathan, Anand; Dwivedi, Ved Prakash; Das, Gobardhan (2021-08-20). "Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis". PLOS Pathogens. 17 (8): e1009805. doi:10.1371/journal.ppat.1009805. ISSN 1553-7374. PMC 8409628. PMID 34415976.
- ^ Singh, Dhiraj Kumar; Tousif, Sultan; Bhaskar, Ashima; Devi, Annu; Negi, Kriti; Moitra, Barnani; Ranganathan, Anand; Dwivedi, Ved Prakash; Das, Gobardhan (2021-08-20). "Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis". PLOS Pathogens. 17 (8): e1009805. doi:10.1371/journal.ppat.1009805. ISSN 1553-7374. PMC 8409628. PMID 34415976.
- ^ Ahmad, Shaheer; Bhattacharya, Debapriya; Gupta, Neeta; Rawat, Varsha; Tousif, Sultan; Kaer, Luc Van; Das, Gobardhan (2020-05-21). "Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells". PLOS Pathogens. 16 (5): e1008356. doi:10.1371/journal.ppat.1008356. ISSN 1553-7374. PMC 7269335. PMID 32437421.
- ^ Singh, Dhiraj Kumar; Dwivedi, Ved Prakash; Singh, Shashi Prakash; Kumari, Anjna; Sharma, Saurabh Kumar; Ranganathan, Anand; Kaer, Luc Van; Das, Gobardhan (2020-09-21). "Luteolin-mediated Kv1.3 K+ channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice". PLOS Pathogens. 16 (9): e1008887. doi:10.1371/journal.ppat.1008887. ISSN 1553-7374. PMC 7529197. PMID 32956412.
- ^ Chatterjee, Samit; Dwivedi, Ved Prakash; Singh, Yogesh; Siddiqui, Imran; Sharma, Pawan; Kaer, Luc Van; Chattopadhyay, Debprasad; Das, Gobardhan (2011-11-10). "Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner". PLOS Pathogens. 7 (11): e1002378. doi:10.1371/journal.ppat.1002378. ISSN 1553-7374. PMC 3213116. PMID 22102818.
- ^ Raghuvanshi, Shilpa; Sharma, Pawan; Singh, Sarman; Van Kaer, Luc; Das, Gobardhan (2010-12-14). "Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells". Proceedings of the National Academy of Sciences. 107 (50): 21653–21658. Bibcode:2010PNAS..10721653R. doi:10.1073/pnas.1007967107. ISSN 0027-8424. PMC 3003090. PMID 21135221.
- ^ Das, Jyoti; Ren, Guangwen; Zhang, Liying; Roberts, Arthur I.; Zhao, Xin; Bothwell, Alfred L. M.; Van Kaer, Luc; Shi, Yufang; Das, Gobardhan (2009-10-26). "Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation". The Journal of Experimental Medicine. 206 (11): 2407–2416. doi:10.1084/jem.20082286. ISSN 1540-9538. PMC 2768861. PMID 19808254.
- ^ Das, Jyoti; Eynott, Paul; Jupp, Ray; Bothwell, Alfred; Van Kaer, Luc; Shi, Yufang; Das, Gobardhan (December 2006). "Natural killer T cells and CD8+ T cells are dispensable for T cell–dependent allergic airway inflammation". Nature Medicine. 12 (12): 1345–1346. doi:10.1038/nm1206-1345. ISSN 1546-170X. PMID 17151684.